Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 21:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- SEK 50.6T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | SEK 50.9B | SEK 145.00 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | SEK 94.5B | SEK 995.55 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | SEK 67.5B | SEK 994.94 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | SEK 53.5B | SEK 1,268.42 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | SEK 41.2B | SEK 300.61 | 1.24% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | SEK 74.9B | SEK 953.79 | 1.59% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | SEK 100B | SEK 661.59 | 1.88% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | SEK 48.7B | SEK 865.03 | 1.01% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | SEK 232.4B | SEK 202.72 | 1.97% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | SEK 287.9B | SEK 397.28 | 0.59% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | SEK 76B | SEK 218.12 | 2.24% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | SEK 88.6B | SEK 3,170.30 | 1.87% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | SEK 46B | SEK 419.82 | 0.48% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | SEK 397.1B | SEK 690.55 | 1.38% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | SEK 458.6B | SEK 393.00 | 8.74% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | SEK 322.9B | SEK 523.62 | 0.75% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | SEK 79.1B | SEK 470.90 | 1.43% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | SEK 697.5B | SEK 218.32 | 0.66% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | SEK 82.5B | SEK 1,264.65 | 2.47% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | SEK 58.5B | SEK 2,925.97 | 3.94% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | SEK 3.34T | SEK 1,354.28 | 3.61% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | SEK 47.3B | SEK 492.52 | 3.86% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | SEK 62.5B | SEK 1,539.98 | 3.33% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | SEK 154.8B | SEK 2,411.12 | 4.57% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | SEK 6.56T | SEK 2,724.07 | 2.04% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | SEK 63.6B | SEK 973.93 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | SEK 12.27T | SEK 13,777.59 | 2.29% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | SEK 1.22T | SEK 594.90 | 2.05% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | SEK 171.2B | SEK 2,610.07 | 5.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | SEK 974B | SEK 9,415.45 | 2.35% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | SEK 1.35T | SEK 5,309.25 | 2.94% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | SEK 134B | SEK 268.08 | 1.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | SEK 2.91T | SEK 1,542.01 | 2.57% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | SEK 5.11T | SEK 2,891.30 | 0.86% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | SEK 242.8B | SEK 5,701.23 | 3.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | SEK 155.3B | SEK 797.21 | 0.22% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | SEK 82.6B | SEK 1,191.03 | 1.88% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | SEK 121.3B | SEK 626.31 | 0.02% down | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | SEK 465.6B | SEK 4,075.80 | 0.97% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | SEK 1.6T | SEK 280.83 | 1.85% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | SEK 62.9B | SEK 445.11 | 1.25% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | SEK 126.1B | SEK 151.22 | 1.00% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | SEK 977.4B | SEK 487.63 | 1.56% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | SEK 2.77T | SEK 1,788.68 | 1.87% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | SEK 56.9B | SEK 83.62 | 3.19% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | SEK 1.13T | SEK 469.68 | 2.25% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | SEK 72.8B | SEK 1,383.55 | 1.25% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | SEK 72.5B | SEK 662.61 | 4.15% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | SEK 1.83T | SEK 1,059.18 | 0.58% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | SEK 1.75T | SEK 396.36 | 1.42% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | SEK 73.1B | SEK 524.75 | 0.27% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | SEK 49.2B | SEK 282.87 | 0.25% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | SEK 49.7B | SEK 594.75 | 3.16% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | SEK 334.7B | SEK 823.83 | 5.59% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | SEK 94B | SEK 4,045.62 | 0.34% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | SEK 72B | SEK 822.40 | 3.79% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | SEK 86.2B | SEK 107.78 | 0.67% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | SEK 323.2B | SEK 1,473.08 | 20.58% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | SEK 31.8B | SEK 164.17 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | SEK 46.2B | SEK 277.57 | 0.62% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | SEK 201.9B | SEK 1,507.34 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1972 SEK).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 21:26 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of SEK 50.6T as of 19 Nov 2026, 21:26 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.